Hoxton Financial’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Hoxton Financial’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$0	Buy	+2,039	New	+$221	﹤0.01%	392
2015 Q4	–	Sell	-2,039	Closed	–	–	403
2015 Q3	$0	Hold	2,039	–	–	﹤0.01%	397
2015 Q2	$1K	Hold	2,039	–	–	﹤0.01%	341
2015 Q1	$1K	Hold	2,039	–	–	﹤0.01%	327
2014 Q4	$2K	Hold	2,039	–	–	﹤0.01%	314
2014 Q3	$1K	Hold	2,039	–	–	﹤0.01%	319
2014 Q2	$1K	Hold	2,039	–	–	﹤0.01%	313
2014 Q1	$1K	Hold	2,039	–	–	﹤0.01%	330
2013 Q4	$1K	Buy	+2,039	New	+$2.46K	﹤0.01%	693
2013 Q3	–	Sell	-2,039	Closed	-$4K	–	704
2013 Q2	$4K	Buy	+2,039	New	+$3.58K	﹤0.01%	534

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Hoxton Financial's GCVRZ Position: Q1 2016 in Review

Hoxton Financial opened a new position in Sanofi Contingent Value Rights (GCVRZ) in Q1 2016: 2,039 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #392 among its holdings. This is a return to the name: Hoxton Financial previously reported a position in GCVRZ as recently as Q3 2015.

Hoxton Financial first reported a position in GCVRZ in Q2 2013 and has held it in 10 quarters since. The position peaked at $4K in Q2 2013. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2016.

Hoxton Financial held 2,039 shares of Sanofi Contingent Value Rights worth $0 as of Q1 2016.
Sanofi Contingent Value Rights was a new Hoxton Financial position in Q1 2016.
Sanofi Contingent Value Rights made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #392 holding.
Hoxton Financial first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 10 quarters since.
Hoxton Financial's Sanofi Contingent Value Rights position peaked at $4K in Q2 2013.
106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.